Related Experiment Video
Updated: Jun 22, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Insights
The COVID-19 pandemic saw a rise in new-onset type 1 diabetes (T1D) in children, especially adolescents. Research explores the link between COVID-19 infection and the development of T1D in pediatric patients.
Area of Science:
- Pediatric Endocrinology
- Infectious Diseases
- Immunology
Background:
- The COVID-19 pandemic presented unique challenges for pediatric populations, with generally milder acute illness compared to adults.
- A notable post-infection complication observed in children and adolescents is the increased incidence of new-onset type 1 diabetes (T1D).
Purpose of the Study:
- To review the epidemiology of COVID-19 and type 1 diabetes (T1D) during the pandemic.
- To explore the proposed mechanisms linking COVID-19 infection to T1D development in pediatric patients.
- To highlight the need for further research on the long-term effects of COVID-19 on T1D in children and adolescents.
Main Methods:
- This is a review article, synthesizing existing literature and data.
- The review examines epidemiological trends of COVID-19 and T1D in pediatric populations.
- Proposed etiological mechanisms are discussed based on current scientific understanding.
Main Results:
- Pediatric COVID-19 cases typically presented with milder illness than adults.
- An increased incidence of new-onset type 1 diabetes (T1D) was observed in children and adolescents following COVID-19 infection.
- Specific demographic groups, particularly adolescents, showed a higher susceptibility.
Conclusions:
- COVID-19 infection is increasingly suspected as a contributing factor to the development of type 1 diabetes in pediatric patients.
- Understanding the precise mechanisms is crucial for managing and potentially preventing T1D post-COVID-19.
- Long-term studies are essential to fully comprehend the pandemic's impact on pediatric T1D incidence and outcomes.
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic brought about several challenges for pediatric patients that were considerably different than those for adult patients. While adult patients had severe illness with associated respiratory and multiorgan failure and subsequent death, pediatric patients typically had milder disease. There were increases in postinfection complications, including an increased incidence of new-onset type 1 diabetes (T1D) following COVID-19 infection, particularly in adolescent patients. Currently, there is increasing concern that COVID-19 infection may be contributing to the development of T1D. This review will provide an overview of COVID-19, T1D, and the increased incidence noted during the pandemic, and the proposed mechanism of development of T1D in this specific patient demographic. Future studies will be needed to understand the long-term impact of the COVID-19 pandemic on T1D in children and adolescents. [.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Psychoneuroimmunology: Diabetes and Cancer
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications

